Clinical Trial Detail

NCT ID NCT01942993
Title The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Philip Friedlander
Indications

melanoma

Therapies

Vemurafenib

Age Groups: senior adult

Additional content available in CKB BOOST